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Abstract
Background Iatrogenic bile duct injury (BDI) is a common
complication after cholecystectomy. Patients are mainly
treated endoscopically, but the optimal treatment method
has remained unclear.
Aims The aim was to analyze endoscopic treatment in BDI
after cholecystectomy and to explore endoscopic sphinc-
terotomy (ES), with or without stenting, as the primary
treatment for an Amsterdam type A bile leak.
Methods All patients referred to Helsinki University
Hospital endoscopy unit due to a suspected BDI between
the years 2004 and 2014 were included in this retrospective
study. To collect the data, all ERC reports were reviewed.
Results Of the 99 BDI patients, 94 (95%) had bile leak of
whom 11 had concomitant stricture. Ninety-three percent
of all patients were treated endoscopically. Seventy-one
patients had native papillae and a leak in the cystic duct or
peripheral radicals. They were treated with ES (ES group,
n = 50) or with sphincterotomy and stenting (EST group,
n = 21). There was no difference between the closure time
of the fistula (p = 0.179), in the time of discharge from
hospital (p = 0.298), or in the primary healing rate
between the ES group and the EST group (45/50 vs 19/21
patients, p = 0.951).
Conclusion After the right patient selection, the success
rate of endoscopic treatment can approach 100% for
Amsterdam type A bile leak. ES is an effective and cost-
effective single procedure with success rate similar to EST.
It may be considered as a first-line therapy for the man-
agement of Amsterdam type A leaks.
Keywords Iatrogenic bile duct injury  Endoscopic
retrograde cholangiopancreatography  Bile leak  Biliary
stent  Sphincterotomy  Amsterdam criteria
Introduction
Iatrogenic bile duct injury (BDI) is still quite common
complication of cholecystectomy. The BDI rate has varied
between 0.42 and 1.1% in earlier studies [1–5]. Bile leak is
the most common type of injury, and it can originate at any
site in the biliary tree. The cystic duct stump or aberrant
biliary duct together with peripheral radicals in the liver is
the most common site of the leak [2, 3].
The goal in endoscopic retrograde cholangiography
(ERC) is to diagnose and treat the injury. Endoscopic
therapy in biliary leak is safe and efficacious, and has been
reported to be successful in 70–100% of cases [5–8].
Principle of the treatment of bile leak is to negate the
transpapillary pressure gradient to facilitate the flow of bile
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into the duodenum instead of extravasation via the leak.
The principal treatment of bile duct stricture, with or
without bile leak, is dilatation of bile duct with stents.
Although ERC is the treatment method of choice for most
BDIs nowadays, the right method used varies. The endo-
scopic therapy options for BDI are sphincterotomy (ES),
stenting with plastic or covered self-expandable metallic
stents with or without ES, and nasobiliary drainage.
Several classifications have been developed to describe
the severity of BDI and to guide the treatment of injury.
One of the most used classifications is the Amsterdam
classification, which is quite practical to use for endoscopic
purposes (Table 1) [7]. In Amsterdam type A bile duct
injuries, the treatment of choice is ES or biliary stenting
with or without ES, and percutaneous drainage if needed
[7–14]. Type B lesions can also mainly be treated endo-
scopically, as well as some of the type C lesions. In more
severe type D BDIs, reconstructive surgery is often even-
tually needed [7, 15]. Type D lesions can be also treated
with a mini-invasive approach by means of endoscopic and
radiologic extra-anatomical rendezvous reconstruction
[16, 17].
Helsinki University Hospital (HUH) is a teaching uni-
versity hospital serving an area of more than one million
inhabitants in South Finland. Laparoscopic cholecystec-
tomies are performed at several hospitals in this area, but
the patients are mainly referred to HUH if a BDI is sus-
pected. The aim of this study was to analyze endoscopic
treatment of BDI after cholecystectomy at HUH. Special
interest was to compare ES, with or without stenting, as the
primary treatment method for Amsterdam type A BDI.
Materials and Methods
To find out the incidence of BDI in Helsinki (588,000
inhabitants in 2010), we searched through all the patient
records of cholecystectomies for a 2-year period
2010–2011 at HUH. A total of 1667 cholecystectomies
were performed, and 18 BDIs were encountered during that
time, giving an overall BDI incidence 1.1%. The annual
incidence of cholecystectomy in Helsinki was 141 per
100,000 inhabitants. During a 10-year period (2004–2014),
120 patients were referred to HUH endoscopic unit due to a
suspected BDI. Ninety-nine of these patients demonstrated
post-cholecystectomy bile leak or stricture on ERC, and
they were included in this study. BDI was confirmed in
ERC or in other imaging examinations, such as abdominal
computed tomography (CT), abdominal ultrasound (US),
and/or magnetic resonance imaging (MRI). All the ERC
procedures were performed or supervised by four experi-
enced interventional endoscopists who each perform
around 300 ERCPs a year; our total number of ERCPs is
more than 1200 per year. To collect the data for this study,
all reports about ERC patients were reviewed retrospec-
tively regarding the baseline demographics, the clinical
features of the biliary injury, the time between surgery and
ERC, the type of ERC management, the presence of biliary
stones, the healing and follow-up times, and the adverse
events during and after ERC.
The severity of the leak was graded by reviewing the
endoscopic images, and it was classified according to the
Amsterdam criteria [18]. The leak was graded as ‘‘low
grade’’ (LG) if the leak of contrast agent was visible in
cholangiography from the distal part of the common bile
duct only after opacification of the intrahepatic biliary
radicals. A ‘‘high-grade’’ (HG) leak was defined if the leak
was seen before intrahepatic opacification [14].
The treatment was determined by the endoscopists based
on personal experience and published information at the
time of the procedure. The endoscopic therapeutic options
were stenting with or without ES or ES alone, bile duct
dilatation, or placement of nasobiliary drainage. The
technique to do ES was to cut the whole sphincter as far as
the duodenal wall, and we confirmed the size of the
sphincterotomy with 11.5-mm balloon sweep through the
papilla after cutting. If remnant bile duct stones were
found, they were also removed.
Primary healing of the leak was defined as the resolution
of symptoms or by cessation of drainage in patients with
the drain without adverse events. Healing of the strictures
was defined when no visible stricture could be seen in the
control ERC when the stents were removed, and liver
enzymes were at normal level. ERC-related adverse events
were classified and graded according to consensus criteria
[19, 20].
The statistical analyses were performed using SPSS 22.0
(IBM Corporation, Somers, NY) statistical software. The
results are given in median and range for continuous
variables, and proportions for categorical variables. Com-
parisons are made between groups using the Chi-square test
or Fisher’s exact test for categorical variables and a non-
parametric Wilcoxon–Mann–Whitney U test for continu-
ous and ordinal variables.
Table 1 Amsterdam classification of severity of bile duct injury
Type
A Leak from cystic duct or peripheral radicals
B Major bile duct injury with leak
C Bile duct stricture without leak
D Complete transection or excision of common bile duct
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Results
The patients’ characteristics are outlined in Table 2. Forty-
five percent of the operations were performed due to acute
cholecystitis, and the median time of the onset of the
symptoms of cholecystitis was 5 days (range 1–60). In
62% of the operations, intraoperative problems were
reported (Table 2). The median time of the beginning of
BDI symptoms after cholecystectomy was 2 days (range
0–240). The most common symptoms of BDI were
abdominal pain (49%) and percutaneous bile leak through
intraoperatively placed drain (44%). If there was no drain
or no visible bile leak via the drain, diagnosis was made by
US (46%), CT (31%), and/or MRI (29%). The usual find-
ing in radiologic examinations was intraabdominal liquid.
The median delay from operation to endoscopic treatment
was 7 days (range 1–82) in patients with bile leak, and
21 days (range 4–1064) in patients with stricture without
leak.
Of the 99 BDI patients, 95 (96%) had bile leak. Seven
patients with leaks had concomitant stricture, and only five
patients had stricture without leak. The most common type
of injury was cystic duct leak with or without other com-
plications in 61%, followed by 21% with leak from the
duct of Luschka or peripheral biliary radicals. The type of
BDI according to Amsterdam classification and endoscopic
therapy is shown in Table 3. Endoscopically could be
treated 93% of all the patients. In seven patients (7%), the
ERC procedure remained diagnostic and further surgery
was needed due to major BDI for eventual treatment right
after the ERC.
There were two cases (2%) of post-ERC pancreatitis
(mild and moderately severe according to Atlanta classifi-
cation) but no cases of bleeding, perforation, cholangitis, or
mortality related to the endoscopic treatment.
Management of Amsterdam Type A Injuries
Of the 74 patients with Amsterdam type A injuries, all
patients were successfully treated endoscopically. We
could identify a group of 71 patients who had native
papillae and were treated with ES (ES group, n = 50), or
with ES and stenting (EST group, n = 21). Comparison of
these two groups reveals that the results are very similar,
the primary treatment was equally successful in both of the
groups (p = 0.951) (Table 4). There was no difference
between the closure time of the leak (p = 0.179) or the
time of discharge from hospital (p = 0.298). There was no
statistical difference in the primary treatment success
between ES group and EST group in the LG leak (32/35 in
ES group and 11/12 in EST group; p = 1.000, Fisher’s
Table 2 Characteristics of all
the patients (n = 99)
Age (years)* 60 (27–93)
Female 54 (55)
Type of cholecystectomy
Laparoscopic 58 (59)
Open 13 (13)
Conversion from laparoscopic to open cholecystectomy 28 (28)
Elective operation 52 (53)
Acute cholecystitis 45 (45)
Technical problems during surgery reported
Acute cholecystitis 32 (32)
Chronic cholecystitis 17 (17)
Bleeding 5 (5)
Stone in cystic duct 3 (3)
Wide cystic duct 3 (3)
Abscess 2 (2)
Injuries seen intraoperatively
Bile leak 3 (3)
Common bile duct injury 5 (5)
Complete transection of common bile duct 1 (1)
Biloma drainage after operation 79 (80)
Days of fistula closure* 4 (0–52)
Hospitalization days after first ERC* 5 (0–65)
Data are presented as numbers, percentages (%), and *median (range)
ERC endoscopic retrograde cholangiography
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exact test) and the HG leak (13/15 in ES group and 8/9 in
EST group; p = 1.000, Fisher’s exact test) subgroups.
However, all the patients in the EST group needed a second
ERC for stent removal, whereas 90% of the ES group
patients needed just one ERC to be cured. Therefore, there
were significantly more ERCs per patient in the EST group
than in the ES group [2.1 (mean) compared to 1.2,
respectively, p = 0.000]. Five patients (10%) in the ES
group needed stenting after the first ERC. We could not
find any common factor of these five patients who were not
cured after the first ERC and ES. However, all the leaks
were ceased at the time of the third ERC and stent removal,
except for one patient, who needed nasobiliary drain before
the leak was healed. There was no need for surgery in
patients of Amsterdam type A lesion. The median follow-
up time for this group was 51 months (range 1–129). One
patient died 27 days after ERC; the cause of death was
systemic lupus erythematosus and sepsis after a compli-
cated cholecystectomy. There were no other short- or long-
term adverse events in this group.
Management of Amsterdam Type B, C, and D
Injuries
Seventeen patients had Amsterdam type B injuries. The site
of the leak was in the common bile duct (CBD) in four
patients, in the main hepatic duct in five patients, and in the
right hepatic duct in one patient. Seven patients had stric-
ture in the CBD with concomitant cystic stump leak. All
patients except two of the type B injuries were treated
endoscopically with stenting. Three patients (18%) of
Amsterdam type B BDI group needed operative treatment;
they had bile leaks from common hepatic duct and right
hepatic branch. The final outcome for all these patients was
successful.
All four patients with Amsterdam type C injuries were
treated endoscopically without surgery.
All four patients with Amsterdam type D injury were
operated on after a diagnostic ERC, and they all underwent
Roux-en-Y hepaticojejunostomy. Within the median fol-
low-up time of 37 months (range 12–80 months), there
were no late complications in this group.
Table 3 Endoscopic finding
and management in all patients
Number of patients (%)
Type of duct lesion (Amsterdam classification)
A 74 (75)
B 17 (17)
C 4 (4)
D 4 (4)
Location of bile leak
Cystic duct 60 (64)
Duct of Luschka or peripheral radicals 21 (22)
Common bile duct 13 (14)
Grade of the leak
HG 43 (46)
LG 51 (54)
Common bile duct stones 17 (17)
Location of biliary stricture
Common bile duct 8 (67)
Common hepatic duct 2 (17)
Right hepatic duct 2 (17)
Endoscopic management
Endoscopic sphincterotomy 56 (57)
Endoscopic sphincterotomy and biliary stent 37 (37)
Biliary stent alone 1 (1)
HG high grade, LG low grade
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Discussion
When treating Amsterdam type A BDIs, we found that ES
alone and ES with stenting had equally good results in
biliary leak closure, 90% success in both groups. Our study
does not show whether stenting alone is an efficient treat-
ment since we do sphincterotomies to easier the procedure
in nearly all therapeutic ERCs, if there are no higher risks
for bleeding. If the position of guide wire in bile duct is lost
during the ERCP, the cannulation of the papilla will be
easier, quicker, and also safer after sphincterotomy.
Despite frequent sphincterotomies, the risk of pancreatitis,
bleeding, and perforation has been low in our unit among
the native papilla patients including ERPs (3.8, 0.75, and
0.56%, respectively) [21]. In the present study, there were
no perforations in ES or EST groups. Although the role of
endoscopic management of BDIs has already been estab-
lished for decades, it has remained unclear what the opti-
mal endoscopic procedure is, especially when treating
these Amsterdam type A BDIs. Of all the patients referred
to our unit due to BDI, 93% could be treated endoscopi-
cally. Seven percent were operated on after the diagnostic
ERC. The success of endoscopic treatment was 100% in
Amsterdam type A and type C BDI patients. We also
managed to treat endoscopically the majority of Amster-
dam type B BDIs (82%), and our success rate was higher
than in previous studies [7, 10].
There are many studies showing the effectiveness of
endoscopic stenting alone in treatment of biliary leaks after
cholecystectomy. Marks et al. [22, 23] have shown in their
study with dogs that biliary stenting is superior to ES when
treating cystic stump leaks. Kaffes et al. [6] stated that stent
insertion alone was superior to ES alone. Dolay et al. [13]
concluded in their randomized prospective study of 27
patients that biliary stenting is a more effective method
than ES in the management of bile leak on post-chole-
cystectomy patients without common bile duct dilatation.
There are also some studies that show that ES alone could
Table 4 Comparison of endoscopic sphincterotomy (ES group), and endoscopic sphincterotomy and stenting group (EST group) for Amsterdam
type A BDIs
ES group n = 50 EST group n = 21 p value
Female 27 (54) 12 (57) 0.808a
Age (years)* 57 (27–88) 66 (32–93) 0.053b
Type of leak
Cystic stump 32 (64) 16 (76) 0.316a
Duct of Luschka or peripheral radical 18 (36) 5 (24) 0.316a
Low-grade leak/high-grade leak 35/15 (69/31) 12/9 (57/43) 0.296a
Endoscopic treatment
1. ERC success 45 (90) 19 (90) 0.951a
2. ERC number and procedure 5 plastic stent 19 stent removal
? 1 stone removal and stenting
? 1 stent change
3. ERC 5 stent removal 1 stent removal
? 1 nasobiliary stent 1 diagnostic
1 additional stent
4. ERC 1 stent removal
Total number of ERCs 60 46 0.000c
Drainage days after ERC* 4 (0–21) 3 (1–14) 0.179c
Hospitalization days after ERC* 4 (1–53) 4 (1–65) 0.298c
Stent days* 40 (31–63) 54 (29–297) 0.338c
Follow-up time, months* 51 (1–129) 28 (1–116) 0.028c
Post-ERCP pancreatitis 2 (4) 0 (0) 0.353a
Data are presented as numbers and percentages (%) of patients or as *median (range)
BDI biliary duct injury
aChi-square test
bUnpaired independent t test
cWilcoxon–Mann–Whitney test
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be the primary treatment for Amsterdam type A bile duct
injuries. Sandha et al. [14] showed in their study of 207 bile
leak patients that ES alone is an effective treatment for the
LG leaks. For the HG leaks, they still recommended biliary
stenting. Aksoz et al. [12] showed in their 31-patient study
that ES is an effective treatment (87% success rate) when
treating LG biliary leak. They recommend stenting as the
primary treatment for HG leaks and for LG leaks only, if
treatment with ES fails. In our study, there was no differ-
ence in length of hospital stay or time of the fistula closure
between the groups; both therapies seem to be equally
effective. In our study, we had good results treating
Amsterdam type A HG leaks with ES alone with success
rate of 87%. If the ES is the only treatment, it has to be
done properly. In our unit, the ES is performed to divide
the sphincter completely by extending the incision to the
maximum safe limit. Smaller ES may not be effective
enough when treating leaks, and this may have been the
reason of poorer outcomes in previous studies. There was
no need for surgery even if the first endoscopic treatment
failed. The ES group needed additional ERCs for 20% of
patients, whereas the ES and stenting group needed addi-
tional ERCPs for 24% of patients after the second (stent
removal) ERC. Stents can also be removed with upper
endoscopy using either an end- or side-viewing endoscope
without performing ERCP, and this could reduce costs and
risk effects. However, in our clinic we have the policy that
when there is a need for a stent removal, we do perform
ERC to get the information if the leak is healed.
Published data support early use of ERC to exclude
major biliary injury and to treat the bile leak or stricture
endoscopically. The clinical condition of BDI patients may
rapidly deteriorate within a few days, if peritonitis, ileus,
and sepsis develop. Forty-eight percent of our patients had
a drain placed in the primary operation, which made the
BDI diagnosis and treatment faster. The median delay for
the ERC was 4 days if the drain was placed in the primary
operation, and as much as 10 days if the drain was placed
radiologically after the initial cholecystectomy. If there is
any suspicion of BDI during the cholecystectomy, it is
highly recommended to leave a drain to avoid delay.
This is a retrospective study, and we are aware of its
limitations. For instance, the exact fistula closure time
cannot be determined since no serial repeat cholangiogra-
phies were performed. However, we can show here that the
accuracy of endoscopic diagnostics is good, and after the
correct patient selection, the success rate of endoscopic
therapy can approach even 100%. Drain placement is
always recommended if there are difficulties with the
anatomy of the biliary tree during the operation. We found
ES as effective as EST in treating Amsterdam type A BDIs.
As an effective and cost-effective single procedure, ES
may be considered as the first treatment method in the
management of Amsterdam type A BDI.
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